79 related articles for article (PubMed ID: 7304209)
1. Effect of vasoactive intestinal polypeptide on cerebral blood flow in the goat.
Larsen JJ; Boeck V; Ottesen B
Acta Physiol Scand; 1981 Apr; 111(4):471-4. PubMed ID: 7304209
[TBL] [Abstract][Full Text] [Related]
2. Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion.
Lundberg JM; Anggård A; Fahrenkrug J
Acta Physiol Scand; 1982 Mar; 114(3):329-37. PubMed ID: 6182751
[TBL] [Abstract][Full Text] [Related]
3. Effect of vasoactive intestinal polypeptide (VIP) upon myometrial blood flow in non-pregnant rabbit.
Ottesen B; Fahrenkrug J
Acta Physiol Scand; 1981 Jun; 112(2):195-201. PubMed ID: 7315413
[TBL] [Abstract][Full Text] [Related]
4. Increased myometrial blood flow evoked by vasoactive intestinal polypeptide in the non-pregnant goat.
Carter AM; Einer-Jensen N; Fahrenkrug J; Ottesen B
J Physiol; 1981 Jan; 310():471-80. PubMed ID: 7230045
[TBL] [Abstract][Full Text] [Related]
5. Effects of vasoactive intestinal polypeptide on blood flow, motility and fluid transport in the gastrointestinal tract of the cat.
Eklund S; Jodal M; Lundgren O; Sjöqvist A
Acta Physiol Scand; 1979 Apr; 105(4):461-8. PubMed ID: 452923
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal polypeptide (VIP): effect on rabbit uterine smooth muscle in vivo and in vitro.
Ottesen B
Acta Physiol Scand; 1981 Oct; 113(2):193-9. PubMed ID: 6947684
[TBL] [Abstract][Full Text] [Related]
7. Effect of autonomic blocking agents on local cerebral blood flow in the rat.
Szabó L; Kovách AG; Babosa M
Acta Physiol Hung; 1983; 62(3-4):191-204. PubMed ID: 6666603
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal polypeptide-sensitive cyclic adenosine monophosphate generating system in the rat portal vein.
Amenta D; Iacopino L; Amenta F
Arch Int Pharmacodyn Ther; 1988; 291():88-95. PubMed ID: 2835024
[TBL] [Abstract][Full Text] [Related]
9. Synergistic hypotensive effect of vasoactive intestinal polypeptide and alpha-blockade with phentolamine. Evidence for vasoactive intestinal peptide alpha-adrenoceptor coupling in the cardiovascular system of newborn dogs.
Mas MS; Adams DJ; Gelband H
Circ Res; 1990 Oct; 67(4):986-92. PubMed ID: 2170054
[TBL] [Abstract][Full Text] [Related]
10. Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion. II. Effects of cholinergic antagonists and VIP antiserum.
Lundberg JM; Anggård A; Fahrenkrug J
Acta Physiol Scand; 1981; 113(3):329-36. PubMed ID: 7345899
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal polypeptide and the canine cerebral circulation.
Wilson DA; O'Neill JT; Said SI; Traystman RJ
Circ Res; 1981 Jan; 48(1):138-48. PubMed ID: 7438343
[TBL] [Abstract][Full Text] [Related]
12. Cerebral vascular effects of peptide histidine methionine in canine and bovine species.
Suzuki Y; Satoh S; Lederis K; Rorstad O
Pharmacology; 1991; 42(5):241-5. PubMed ID: 1876608
[TBL] [Abstract][Full Text] [Related]
13. Evidence for coexistence of vasoactive intestinal polypeptide (VIP) and acetylcholine in neurons of cat exocrine glands. Morphological, biochemical and functional studies.
Lundberg JM
Acta Physiol Scand Suppl; 1981; 496():1-57. PubMed ID: 7030007
[No Abstract] [Full Text] [Related]
14. Cortical vasodilatation produced by vasoactive intestinal polypeptide (VIP) and by physiological stimuli in the cat.
Yaksh TL; Wang JY; Go VL
J Cereb Blood Flow Metab; 1987 Jun; 7(3):315-26. PubMed ID: 3108270
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the vasodilatory effects of vasoactive intestinal polypeptide (VIP) and peptide-HI (PHI) in the rabbit and the cat.
Nilsson SF; Mäepea O
Acta Physiol Scand; 1987 Jan; 129(1):17-26. PubMed ID: 3565040
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal polypeptide (VIP) as a possible neurotransmitter involved in penile erection.
Willis E; Ottesen B; Wagner G; Sundler F; Fahrenkrug J
Acta Physiol Scand; 1981 Dec; 113(4):545-7. PubMed ID: 7348038
[No Abstract] [Full Text] [Related]
17. [PRF activity of VIP in vitro (author's transl)].
Arancibia S; Enjalbert A; Ruberg M; Priam M; Bluet-Pajot MT; Kordon C
J Physiol (Paris); 1981 Mar; 77(8):979-83. PubMed ID: 6122734
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal polypeptide (VIP).
Miller RJ
Med Biol; 1980 Aug; 58(4):179-81. PubMed ID: 7266081
[No Abstract] [Full Text] [Related]
19. Distribution and motor effect of VIP in female genital tract.
Ottesen B; Larsen JJ; Fahrenkrug J; Stjernquist M; Sundler F
Am J Physiol; 1981 Jan; 240(1):E32-6. PubMed ID: 7006413
[TBL] [Abstract][Full Text] [Related]
20. [Vasoactive intestinal polypeptide (VIP) (author's transl)].
Kachelhoffer J; Marescaux J; Michel F; Grenier JF
Gastroenterol Clin Biol; 1979 Apr; 3(4):381-95. PubMed ID: 499699
[No Abstract] [Full Text] [Related]
[Next] [New Search]
